PMID- 30802413 OWN - NLM STAT- MEDLINE DCOM- 20200413 LR - 20231213 IS - 2472-5560 (Electronic) IS - 2472-5552 (Linking) VI - 24 IP - 5 DP - 2019 Jun TI - A General Guide for the Optimization of Enzyme Assay Conditions Using the Design of Experiments Approach. PG - 587-596 LID - 10.1177/2472555219830084 [doi] AB - Many factors must be considered during the optimization of an enzyme assay. These include the choice of buffer and its composition, the type of enzyme and its concentration, as well as the type of substrate and concentrations, the reaction conditions, and the appropriate assay technology. The process of an enzyme assay optimization, in our experience, can take more than 12 weeks using the traditional one-factor-at-a-time approach. In contrast, the design of experiments (DoE) approaches have the potential to speed up the assay optimization process and provide a more detailed evaluation of tested variables. However, not all researchers are aware of DoE approaches or believe that it is easy to employ a DoE approach for the optimization of an assay. In order to facilitate enzyme assay developers to use DoE methodologies, we present in detail the steps required to identify in less than 3 days (1) the factors that significantly affect the activity of an enzyme and (2) the optimal assay conditions using a fractional factorial approach and response surface methodology. This is exemplified with the optimization of assay conditions for the human rhinovirus-3C protease, and the methodology used could be employed as a basic guide for the speedy identification of the optimum assay conditions for any enzyme. FAU - Onyeogaziri, Favour Chinyere AU - Onyeogaziri FC AD - 1 Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia, Cyprus. FAU - Papaneophytou, Christos AU - Papaneophytou C AUID- ORCID: 0000-0002-4045-8839 AD - 1 Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia, Cyprus. LA - eng PT - Journal Article DEP - 20190225 PL - United States TA - SLAS Discov JT - SLAS discovery : advancing life sciences R & D JID - 101697563 RN - 0 (Viral Proteins) RN - EC 3.4.22.- (Cysteine Endopeptidases) RN - EC 3.4.22.28 (3C Viral Proteases) SB - IM MH - 3C Viral Proteases MH - Biological Assay/*methods MH - Cysteine Endopeptidases/*chemistry MH - Enzyme Assays/*methods MH - Humans MH - Research Design MH - Substrate Specificity MH - Viral Proteins/*chemistry OTO - NOTNLM OT - assay optimization OT - design of experiments OT - enzyme activity OT - fractional factorial OT - response surface methodology EDAT- 2019/02/26 06:00 MHDA- 2020/04/14 06:00 CRDT- 2019/02/26 06:00 PHST- 2019/02/26 06:00 [pubmed] PHST- 2020/04/14 06:00 [medline] PHST- 2019/02/26 06:00 [entrez] AID - S2472-5552(22)06779-X [pii] AID - 10.1177/2472555219830084 [doi] PST - ppublish SO - SLAS Discov. 2019 Jun;24(5):587-596. doi: 10.1177/2472555219830084. Epub 2019 Feb 25.